Mechanism of action of the antiviral compound MDL 20,610.
作者信息
Kenny M T, Torney H L, Dulworth J K
机构信息
Department of Pharmacology, Merrell Dow Research Institute, Indianapolis, Indiana 46268-0470.
出版信息
Antiviral Res. 1988 Jul;9(4):249-61. doi: 10.1016/0166-3542(88)90056-3.
Abstract
The purpose of this study was to probe the antirhinovirus (RV) mechanism of action of MDL 20,610. Evaluation of the compound's effects on RV RNA synthesis, uncoating of neutral red-sensitized RV, plasma membrane penetration by RV, stabilization of RV against heat (56 degrees C) and low pH (5.0) inactivation, and studies with MDL 20,610-resistant RV mutants indicate that MDL 20,610 binds directly to the RV capsid with subsequent inhibition of acid-mediated virion uncoating.
摘要
相似文献
1
Mechanism of action of the antiviral compound MDL 20,610.
Antiviral Res. 1988 Jul;9(4):249-61. doi: 10.1016/0166-3542(88)90056-3.
2
Mechanism of action of the antirhinovirus flavanoid 4',6-dicyanoflavan.
Antimicrob Agents Chemother. 1992 Jan;36(1):95-9. doi: 10.1128/AAC.36.1.95.
3
Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
J Virol. 2022 Jan 26;96(2):e0106021. doi: 10.1128/JVI.01060-21. Epub 2021 Oct 27.
4
In vitro antiviral activity of the 6-substituted 2-(3',4'-dichlorophenoxy)-2H-pyrano[2,3-b]pyridines MDL 20,610, MDL 20,646, and MDL 20,957.
Antimicrob Agents Chemother. 1986 Sep;30(3):516-8. doi: 10.1128/AAC.30.3.516.
5
Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization.
Arch Virol. 1989;106(1-2):51-61. doi: 10.1007/BF01311037.
6
Studies of rhinovirus resistant to an antiviral chalcone.
Antiviral Res. 1987 Aug;8(1):27-39. doi: 10.1016/0166-3542(87)90085-4.
7
WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14.
J Virol. 1993 Apr;67(4):2245-54. doi: 10.1128/JVI.67.4.2245-2254.1993.
8
Effect of dichloroflavan (BW683C) on the stability and uncoating of rhinovirus type 1B.
J Antimicrob Chemother. 1984 Aug;14 Suppl A:97-105. doi: 10.1093/jac/14.suppl_a.97.
9
SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
Antiviral Res. 1995 Jan;26(1):65-82. doi: 10.1016/0166-3542(94)00066-h.
10
Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
J Mol Biol. 1996 May 31;259(1):120-34. doi: 10.1006/jmbi.1996.0307.
引用本文的文献
1
Picornavirus inhibitors.
Pharmacol Ther. 1994;64(2):215-90. doi: 10.1016/0163-7258(94)90040-x.
2
Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization.
Arch Virol. 1989;106(1-2):51-61. doi: 10.1007/BF01311037.
3
6-(3,4-Dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile inhibits poliovirus uncoating.
Antimicrob Agents Chemother. 1990 Jun;34(6):1259-61. doi: 10.1128/AAC.34.6.1259.
4
Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.
Antimicrob Agents Chemother. 1991 Jun;35(6):1040-7. doi: 10.1128/AAC.35.6.1040.
5
Study of the parameters of binding of R 61837 to human rhinovirus 9 and immunobiochemical evidence of capsid-stabilizing activity of the compound.
Antimicrob Agents Chemother. 1992 Feb;36(2):417-24. doi: 10.1128/AAC.36.2.417.
本文引用的文献
1
Antiviral activity and mechanism of action of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile (MDL-860).
Antimicrob Agents Chemother. 1982 Oct;22(4):635-8. doi: 10.1128/AAC.22.4.635.
2
Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.
Antimicrob Agents Chemother. 1982 Oct;22(4):617-21. doi: 10.1128/AAC.22.4.617.
3
Antipicornavirus flavone Ro 09-0179.
Antimicrob Agents Chemother. 1982 Oct;22(4):611-6. doi: 10.1128/AAC.22.4.611.
4
Pathogenesis of experimental skin infections induced by drug-resistant herpes simplex virus mutants.
Infect Immun. 1981 Dec;34(3):693-701. doi: 10.1128/iai.34.3.693-701.1981.
5
Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.
Antimicrob Agents Chemother. 1980 Feb;17(2):209-16. doi: 10.1128/AAC.17.2.209.
6
Antivirus agent, Ro 09-0410, binds to rhinovirus specifically and stabilizes the virus conformation.
Virology. 1984 Apr 30;134(2):269-76. doi: 10.1016/0042-6822(84)90296-4.
7
Effect of dichloroflavan (BW683C) on the stability and uncoating of rhinovirus type 1B.
J Antimicrob Chemother. 1984 Aug;14 Suppl A:97-105. doi: 10.1093/jac/14.suppl_a.97.
8
Differences between the thermal inactivation of picornaviruses at "high" and "low" temperatures.
Virology. 1967 Feb;31(2):338-53. doi: 10.1016/0042-6822(67)90179-1.
9
WIN 51711, a new systematically active broad-spectrum antipicornavirus agent.
J Antimicrob Chemother. 1985 Sep;16(3):284-6. doi: 10.1093/jac/16.3.284.
10
In vitro and in vivo anti-picornavirus activity of some p-benzoylphenoxypyridines.
Antiviral Res. 1986 Oct;6(6):355-67. doi: 10.1016/0166-3542(86)90017-3.
Zotero 插件